Galera Therapeutics
Stock Forecast, Prediction & Price Target
Galera Therapeutics Financial Estimates
Galera Therapeutics Revenue Estimates
Galera Therapeutics EBITDA Estimates
Galera Therapeutics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | |||
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $0 Low: $0 High: $0 avg. 0% | |||
Net Income
% change YoY
| $-87.72M N/A | $-62.22M 29.07% | $-59.08M 5.04% | Avg: $-34.77M Low: $-34.77M High: $-34.77M avg. 41.13% | |||
EBITDA
% change YoY
| $-72.55M N/A | $-51.22M 29.39% | $-46.69M 8.85% | Avg: $0 Low: $0 High: $0 avg. 100% | |||
EPS
% change YoY
| -$3.4 N/A | -$2.3 32.35% | -$1.33 42.17% | Avg: -$0.78 Low: -$0.78 High: -$0.78 avg. 41.30% | |||
Operating Expenses
% change YoY
| $73.36M N/A | $51.22M -30.17% | $46.95M -8.34% | Avg: $0 Low: $0 High: $0 avg. -100% | |||
FAQ
What is Galera Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 41.13% in 2025-2025.
We have gathered data from N/A analysts. Their low estimate is -34.77M, average is -34.77M and high is -34.77M.
What is Galera Therapeutics stock revenue growth forecast?
We have gathered data from N/A analysts. Their low revenue estimate is N/A, average is N/A and high is N/A.
What is Galera Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 41.30% in 2025-2025.
We have gathered data from N/A analysts. Their low earnings per share estimate is -$0.78, average is -$0.78 and high is $-0.78.